Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Ramachandra Sista
Associate Clinical Professor, Internal Medicine
COM - Phoenix Internal Medicine
Overview
Research
More
Collaboration
(4)
Elena Young
Mutual work: 1 Grant
Collaboration Details
Mason Burchfield
Mutual work: 1 Grant
Collaboration Details
Radha Gopalan
Mutual work: 1 Grant
Collaboration Details
Susan Sheerin-Fadden
Mutual work: 1 Grant
Collaboration Details
Grants
(7)
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Healt
Active
·
2023
·
$189.4K
·
External
Principal Investigator (PI)
cardiopulmonary exercise testing,
pulmonary hypertension,
clinical trial,
drug safety,
exercise capacity
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) in Subjects With Pulmonary Hypert
Active
·
2021
·
$183.3K
·
External
Principal Investigator (PI)
pulmonary hypertension,
nitric oxide,
safety,
efficacy
An Open Label Follow-Up Study to Evaluate the Long Term Safety and Efficacy of L-CSA in Patients with a Diagnosis of CLAD-BOS after they have completed the participation to BOSTON 1 and BOSTON 2 studi
Active
·
2020
·
$432K
·
External
Principal Investigator (PI)
long-term safety,
efficacy,
l-csa,
clad-bos
A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI
Active
·
2020
·
$128.1K
·
External
Principal Investigator (PI)
clinical trials,
drug delivery,
immunosuppression,
liposomal formulations,
respiratory medicine
A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI
Active
·
2019
·
$249.3K
·
External
Principal Investigator (PI)
clinical trials,
inhalation therapy,
liposomal cyclosporine a,
safety and effectiveness
Page 1 of 2
Previous page
Next page
Publications
(1)
Recent
Development of xeno-free epithelial differentiation media for adherent, non-expanded adipose stromal vascular cell cultures
2018